000 01168 a2200313 4500
005 20250516060542.0
264 0 _c20120229
008 201202s 0 0 eng d
022 _a1573-4935
024 7 _a10.1042/BSR20110068
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPérez-Lorenzo, Rolando
245 0 0 _aTargeted inhibition of BRAF kinase: opportunities and challenges for therapeutics in melanoma.
_h[electronic resource]
260 _bBioscience reports
_cFeb 2012
300 _a25-33 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review
650 0 4 _aAnimals
650 0 4 _aClinical Trials as Topic
650 0 4 _aCombined Modality Therapy
650 0 4 _aDisease Models, Animal
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aHumans
650 0 4 _aMelanoma
_xdrug therapy
650 0 4 _aProtein Kinase Inhibitors
_xpharmacology
650 0 4 _aProto-Oncogene Proteins B-raf
_xantagonists & inhibitors
700 1 _aZheng, Bin
773 0 _tBioscience reports
_gvol. 32
_gno. 1
_gp. 25-33
856 4 0 _uhttps://doi.org/10.1042/BSR20110068
_zAvailable from publisher's website
999 _c21215389
_d21215389